tetano
Editor, Senior Moderator
Epidemiol Infect. 2018 Mar 21:1-10. doi: 10.1017/S0950268818000596. [Epub ahead of print]
[h=1]Risk of bias and limits of reporting in diagnostic accuracy studies for commercial point-of-care tests for respiratory pathogens.[/h] Hughes JM[SUP]1[/SUP], Penney C[SUP]1[/SUP], Boyd S[SUP]1[/SUP], Daley P[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Commercial point-of-care (POC) diagnostic tests for Group A Streptococcus, Streptococcus pneumoniae, and influenza virus have large potential diagnostic and financial impact. Many published reports on test performance, often funded by diagnostics companies, are prone to bias. The Standards for Reporting of Diagnostic Accuracy (STARD 2015) are a protocol to encourage accurate, transparent reporting. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool evaluates risk of bias and transportability of results. We used these tools to evaluate diagnostic test accuracy studies of POC studies for three respiratory pathogens. For the 96 studies analysed, compliance was <25% for 14/34 STARD 2015 standards, and 3/7 QUADAS-2 domains showed a high risk of bias. All reports lacked reporting of at least one criterion. These biases should be considered in the interpretation of study results.
[h=4]KEYWORDS:[/h] Streptococcus pneumonia ; Group A Streptococcus ; QUADAS; STARD; influenza; point-of-care
PMID: 29560838 DOI: 10.1017/S0950268818000596
[h=1]Risk of bias and limits of reporting in diagnostic accuracy studies for commercial point-of-care tests for respiratory pathogens.[/h] Hughes JM[SUP]1[/SUP], Penney C[SUP]1[/SUP], Boyd S[SUP]1[/SUP], Daley P[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Commercial point-of-care (POC) diagnostic tests for Group A Streptococcus, Streptococcus pneumoniae, and influenza virus have large potential diagnostic and financial impact. Many published reports on test performance, often funded by diagnostics companies, are prone to bias. The Standards for Reporting of Diagnostic Accuracy (STARD 2015) are a protocol to encourage accurate, transparent reporting. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool evaluates risk of bias and transportability of results. We used these tools to evaluate diagnostic test accuracy studies of POC studies for three respiratory pathogens. For the 96 studies analysed, compliance was <25% for 14/34 STARD 2015 standards, and 3/7 QUADAS-2 domains showed a high risk of bias. All reports lacked reporting of at least one criterion. These biases should be considered in the interpretation of study results.
[h=4]KEYWORDS:[/h] Streptococcus pneumonia ; Group A Streptococcus ; QUADAS; STARD; influenza; point-of-care
PMID: 29560838 DOI: 10.1017/S0950268818000596